Xenon Pharmaceuticals Files 2024 10-K
Ticker: XENE · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1582313
| Field | Detail |
|---|---|
| Company | Xenon Pharmaceuticals Inc. (XENE) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, financials
TL;DR
Xenon Pharma's 2024 10-K is in. Check financials and pipeline updates.
AI Summary
Xenon Pharmaceuticals Inc. filed its 2024 10-K on February 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, operating in pharmaceutical preparations, is based in Burnaby, BC, and its filing includes details on its financial performance and business operations. Key financial data and disclosures related to its drug development programs and corporate structure are presented within the report.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Xenon Pharmaceuticals' financial health and strategic direction for the fiscal year 2024, including details on its drug pipeline and any significant business developments.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Xenon Pharmaceuticals faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the 10-K filing.)
- 2025-02-27 — Filing Date (The date the 10-K was submitted to the SEC.)
Key Players & Entities
- Xenon Pharmaceuticals Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-27 (date) — Filing date
- Burnaby, BC (location) — Company headquarters
- First Order Pharmaceuticals Inc. (company) — Mentioned in relation to an Asset Purchase Agreement
FAQ
What is Xenon Pharmaceuticals Inc.'s primary business?
Xenon Pharmaceuticals Inc. is primarily involved in the pharmaceutical preparations industry, as indicated by its Standard Industrial Classification code [2834].
When did Xenon Pharmaceuticals Inc. file its 10-K report?
Xenon Pharmaceuticals Inc. filed its 10-K report on February 27, 2025.
What fiscal year does this 10-K filing cover?
This 10-K filing covers the fiscal year ending on December 31, 2024.
Where is Xenon Pharmaceuticals Inc. headquartered?
Xenon Pharmaceuticals Inc. is headquartered at 200 - 3650 Gilmore Way, Burnaby, BC, V5G 4B8.
What is the SEC file number for Xenon Pharmaceuticals Inc.'s 10-K?
The SEC file number for Xenon Pharmaceuticals Inc.'s 10-K is 001-36687.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding Xenon Pharmaceuticals Inc. (XENE).